World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
80
Citations
25659
World Ranking
4037
National Ranking
27

Overview

Peter F. Ambros is affiliated with St Anna Children's Hospital in Austria. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with significant contributions in the subfields of Neurology, Cancer Research, Molecular Biology, Genetics, and Oncology.

Their recent publication record includes studies focused on pediatric cancers and neuroblastoma. Notable papers are:

  • Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden, 2021, Nature Communications
  • Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1), 2020, Cancers
  • Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma: A Report From the HR-NBL1/SIOPEN Study, 2020, Journal of Clinical Oncology
  • Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome, 2021, Nature Communications
  • Schwann cell plasticity regulates neuroblastic tumor cell differentiation via epidermal growth factor-like protein 8, 2021, Nature Communications

Frequent collaborators include:

  • Inge M. Ambros
  • Sabine Taschner-Mandl
  • Ruth Ladenstein
  • Fikret Rifatbegovic
  • Marie Bernkopf

Prominent publication venues for their work are:

  • Journal of Clinical Oncology
  • Nature Communications
  • Cancers
  • Zenodo (CERN European Organization for Nuclear Research)
  • Cancer Research

Their primary research topics encompass:

  • Neuroblastoma Research and Treatments
  • Cancer, Hypoxia, and Metabolism
  • Cancer therapeutics and mechanisms
  • Neuroendocrine Tumor Research Advances
  • Virus-based gene therapy research
  • Glioma Diagnosis and Treatment
  • Lung Cancer Research Studies

This profile reflects a career engaged deeply in pediatric oncology research, with particular emphasis on neuroblastoma biology and treatment. The scientist has contributed to advancing molecular understanding and clinical approaches in their areas of study.

Best Publications

  • The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report

    Susan L. Cohn;Andrew D.J. Pearson;Wendy B. London;Tom Monclair

  • Truncating Mutations of hSNF5/INI1 in Aggressive Paediatric Cancer

    Isabella Versteege;Nicolas Sévenet;Julian Lange;Marie-Françoise Rousseau-Merck

  • The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report

    Tom Monclair;Garrett M. Brodeur;Peter F. Ambros;Hervé J. Brisse

  • MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration.

    Inge M. Ambros;Peter F. Ambros;Sabine Strehl;Heinrich Kovar

  • Advances in Risk Classification and Treatment Strategies for Neuroblastoma

    Navin R. Pinto;Mark A. Applebaum;Samuel L. Volchenboum;Katherine K. Matthay

  • Classification of isolated tumor cells and micrometastasis.

    Gabor Mehes;Armin Witt;Ernst Kubista;Peter F. Ambros

  • International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee.

    PF Ambros;IM Ambros;GM Brodeur;M Haber

  • Chromosomally integrated human herpesvirus 6: questions and answers

    Philip E. Pellett;Dharam V. Ablashi;Peter F. Ambros;Henri Agut

  • The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro

    Jesse H. Arbuckle;Maria M. Medveczky;Janos Luka;Stephen H. Hadley

  • Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial

    Ruth Ladenstein;Ruth Ladenstein;Ulrike Pötschger;Andrew D J Pearson;Penelope Brock

  • Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial

    Ruth Ladenstein;Ulrike Pötschger;Dominique Valteau-Couanet;Roberto Luksch

  • hTERT alone immortalizes epithelial cells of renal proximal tubules without changing their functional characteristics.

    Matthias Wieser;Guido Stadler;Paul Jennings;Berthold Streubel

  • Clinical and Biologic Features Predictive of Survival After Relapse of Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project

    Wendy B. London;Victoria Castel;Tom Monclair;Peter F. Ambros

  • Modification of DAPI banding on human chromosomes by prestaining with a DNA-binding oligopeptide antibiotic, distamycin A.

    D. Schweizer;P. Ambros;M. Andrle

  • Circulating Breast Cancer Cells Are Frequently Apoptotic

    Gábor Méhes;Armin Witt;Ernst Kubista;Peter F. Ambros

  • A novel putative tyrosine kinase receptor with oncogenic potential.

    J. W. G. Janssen;A. S. Schulz;A. C. M. Steenvoorden;M. Schmidberger

  • Application of Giemsa banding to orchid karyotype analysis

    Trude Schwarzacher;Peter Ambros;Dieter Schweizer

  • Gene amplification as double minutes or homogeneously staining regions in solid tumors: Origin and structure

    Clelia Tiziana Storlazzi;Angelo Lonoce;Maria C. Guastadisegni;Domenico Trombetta

  • DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma

    Nathan C. Sheffield;Gaelle Pierron;Johanna Klughammer;Paul Datlinger

  • Overexpression of the pseudoautosomal gene MIC2 in Ewing's sarcoma and peripheral primitive neuroectodermal tumor.

    H Kovar;M Dworzak;S Strehl;E Schnell

Frequent Co-Authors

Helmut Gadner
Helmut Gadner St Anna Children's Hospital
Heinrich Kovar
Heinrich Kovar St Anna Children's Hospital
Wendy B. London
Wendy B. London Harvard University
Andrew D.J. Pearson
Andrew D.J. Pearson Royal Marsden NHS Foundation Trust
Susan L. Cohn
Susan L. Cohn University of Chicago
Katherine K. Matthay
Katherine K. Matthay University of California, San Francisco
Genevieve Laureys
Genevieve Laureys Ghent University Hospital
Olivier Delattre
Olivier Delattre PSL University
Tommy Martinsson
Tommy Martinsson University of Gothenburg
Thomas Lion
Thomas Lion Medical University of Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a degree in Biology or Biochemistry opens doors to a wide range of health and science careers. For students interested in imaging or diagnostics, there are online radiology tech programs that offer a flexible and affordable path into healthcare technology fields.

Nutrition-focused students may want to consider the best dietetics programs. These degrees can help you become a registered dietitian or nutrition expert, blending biochemistry with real-world client care.

There are also growing opportunities in patient care and administration. Fast-track your entry into healthcare by considering online medical assisting classes—many of which offer financial aid to help you get started faster.

For certified medical assistants looking to expand their qualifications, the cma to lpn bridge program online offers a streamlined progression to becoming a Licensed Practical Nurse, allowing for greater responsibility and salary potential.

Each pathway brings unique challenges and benefits, but all can help launch a rewarding science-based career in the ever-evolving field of healthcare.

Best Scientists Citing Peter F. Ambros

Trending Scientists

Recently Published Articles